baber/WOPTO huggingface dataset:
Patent DE-69625804-D1 (DE)
Title: Aus aloe barbadensis isoliertes cinnamoyl-c-glykosid chromon
Inventor: WALLER A
IPC: A61K45/06
Filed: 1996-02-20
Granted: 2003-02-20
Abstract: A composition of matter comprising at least 15% by weight of the compound: 8-C- beta -D-[2'- omicron -(E)-cinnamoyl]glycopyranosyl-2-[(S)-2-hydroxyl]propyl-7-methoxy-5-methylchromone. This compound, found in very small amounts in leaves of the Aloe Barbadensis plant, when concentrated to the desired level, exhibits anti-inflammatory activity.
Patent DE-69626671-D1 (DE)
Inventor: KELLEY F
IPC: A61K38/00
Filed: 1996-11-22
Granted: 2003-04-17
Abstract: The invention provides compositions having a Factor VIIa active site inhibitor domain and a tissue factor domain for the inhibition of FVIIa. The invention also provides pharmaceutical compositions comprising the novel compositions as well as their use in diagnostic, therapeutic, and prophylactic methods.
Patent DE-69630440-D1 (DE)
Inventor: DIEHL KRIS R
IPC: A47G19/22
Filed: 1996-01-31
Granted: 2003-11-27
Abstract: A stemmed drinking glass with an upper cup supported by a hollow stem and connected to a base uses a chemiluminescent light stick inserted into the hollow stem to provide illumination. A demountable cup, demountable base, or hole extending upward through the bottom of the base joining the hollow stem and incorporating a plug facilitates insertion, containment, and removal of lightstick.
Patent DE-69630879-D1 (DE)
Inventor: GILCHRIST THOMAS
IPC: A61B17/11
Filed: 1996-04-01
Granted: 2004-01-08
Abstract: PCT No. PCT/GB96/00784 Sec. 371 Date Sep. 30, 1997 Sec. 102(e) Date Sep. 30, 1997 PCT Filed Apr. 1, 1996 PCT Pub. No. WO96/31160 PCT Pub. Date Oct. 10, 1996There is provided a device to promote healing of cut tissue members, such as nerves, tendon or muscles, within a body. The device is of hollow construction and comprises apertures into which the cut ends of the tissue members are placed and fixed, usually by a fibrin-based tissue glue. Located between the apertures is a substance to promote healing of the tissue member such as, for example, nerve growth factor. Optionally the device may be used in conjunction with the external reservoir of the substance and/or with a time-operated pump to deliver the substance to the device. The device is biodegradable and is preferably composed of watersoluble glass.
Patent DE-69700329-D1 (DE)
Inventor: PIGUET PIERRE-LOUIS
IPC: B23B21/00
Filed: 1997-09-01
Granted: 1999-08-19
Abstract: PCT No. PCT/CH97/00318 Sec. 371 Date Apr. 28, 1998 Sec. 102(e) Date Apr. 28, 1998 PCT Filed Sep. 1, 1997 PCT Pub. No. WO98/09755 PCT Pub. Date Mar. 12, 1998The machining unit is composed mainly of three essential elements which are the rotor, the phase displacement device and the tool drive mechanism. The rotor (100) includes a rotating shaft (1) and is equipped, for example, with four bores, extending parallel to the axis of rotation, into which the cutter carrier axles (9a, 9b, 9c and 9d) are supported. A plunge of the cutters into the material to be machined is controlled by the movement of a command sleeve (19) supporting, at its end, two surfaces (20a and 20b) of ellipsoidal form located to move, in conjunction with the inclined surfaces (14a, 14b, 14c and 14d), the command levers of the tool carrier. The command sleeve can occupy two extreme positions and one intermediary position. A phase displacement device includes a pulley (22) and a reverse pulley (25) mounted rotatably on a shaft (31) to allow angular phase change of the command sleeve (19) with respect to the spindle.
Patent DE-69705435-D1 (DE)
Inventor: LOUW JOHN A
IPC: F16B39/286
Filed: 1997-01-24
Granted: 2001-08-09
Abstract: The self-locking internally threaded nut has a deltoid shaped locking section (24) having circumferentially spaced protrusions (40). The protrusions (40) form a surface adapted to be engaged by a deltoid driver which tightens the nut onto a bolt to a predetermined axial load. At the predetermined load the protrusions (40) are plastically deformed inwardly on the nut so that the driver rotates freely on the nut. When the protrusions (40) are inwardly deformed, the deformed material impinges on the bolt, thereby rotationally locking the nut on the bolt. <IMAGE>
Patent DE-69711721-D1 (DE)
Inventor: FAGOT JACQUES
IPC: A43B5/04
Filed: 1997-07-08
Granted: 2002-05-08
Abstract: The assembly is for a ski having a toe stop and heel fixing between the ski and the boot. It comprises a shell (6) and an upper collar (5). The collar is pivoted to the shell of the boot so it can be inclined forwards, especially when making turns. The ski boot collar also has a mechanism connecting it to the ski with the aim of modifying the ski's rigidity or camber when the collar is inclined. The mechanism comprises an arm (10) located at one side of the boot, passing through the axis of the pivot and connected to one end of a lever (12). The lever lies parallel to the upper surface of the ski with its rear end connected to the lower end of the arm (10) and its forward end interacting with a thrust plate (15) which is connected to the upper surface of the ski by a visco-elastic bloc (14).
Patent DE-69720160-D1 (DE)
Inventor: BOUALI YAMINA
IPC: A61K31/58
Filed: 1997-12-22
Granted: 2003-04-30
Abstract: Use of 11-phenyl steroid derivatives of formula (I) and their salts in hormone replacement therapy to treat the effects of the menopause or perimenopause. n = 2 or 3; R1, R2 = H or 1-4C alkyl; or NR1R2 = 5-15 membered optionally unsaturated, mono- or poly-cyclic heterocycle which may contain 1-3 further hetero atoms selected from O, N, S and which may be substituted; X = OH (optionally esterified); and Y = H, 2-4C alkenyl or 2-4C alkynyl; or X+Y = a group of formula (ii), (iii) or (iv); or X+Y = oxo.
Patent DE-69724870-D1 (DE)
Inventor: SCHWEITZER II
IPC: H02J13/00
Filed: 1997-05-27
Granted: 2003-10-23
Abstract: The communication system includes transmitting output status bits indicative of a function of the relay directly from one microprocessor-based protective relay(30) in a power system to a second companion microprocessor-based relay (32). Each relay has transmit (42,48) and receive (50,46) modules connected by a communications link (44), with the transmit and receive modules using the logic output and input bits produced by the respective relays in their respective relay calculations.
Patent DE-69727583-D1 (DE)
Inventor: JOHNSON SUSAN
IPC: A61K35/20
Filed: 1997-09-19
Granted: 2004-03-18
Abstract: Compositions containing at least one compound with Growth Factor-like activity are used for the prophylactic treatment of a gastrointestinal condition at least partially characterised by damage to epithelial cells and caused by administration of a non-steroidal anti-inflammatory drug (e.g. indomethacine).
Patent DE-69729859-D1 (DE)
Inventor: ISELI ANDREAS
IPC: B29C49/48
Filed: 1997-04-01
Granted: 2004-08-19
Abstract: A method of reshaping a hollow tube having a circumferential wall defining an inside and an outside of the tube and formed from at least one layer of a thermoformable plastic, with the outside of the wall having at least one decoration, which method includes the steps of juxtaposing one side of the tube with a forming element having a surface in the shape of a pattern, so that the pattern confronts the side of the tube; and heating the tube wall to an elevated forming temperature at which the plastic is capable of being thermoformed and applying a differential fluid pressure to the tube so that the prevailing pressure on the side of the tube opposite the forming element exceeds the pressure prevailing on the side with the forming element, so that the heated tube wall contacts the forming element surface pattern and is thereby formed into conformity with the shape of the pattern. Methods in which a mandrel is used as the forming element are described.
Patent DE-69733652-D1 (DE)
Inventor: WRIGHT CRAIG
IPC: A61K39/39
Filed: 1997-02-06
Granted: 2005-08-04
Abstract: A new method of adjuvanting a variety of materials has been developed. Starburst dendrimers, primarily poly(amidoamine) starburst dendrimers, can be used as an adjuvant for Influenza antigen and similar materials. Mid-Generation dendrimers are preferred and yield high antibody titer levels with reduced antigen dosage.
Patent DE-69736598-D1 (DE)
Inventor: DUBOIS B
IPC: C12N15/86
Filed: 1997-07-02
Granted: 2006-10-12
Abstract: The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.
Patent DE-69739050-D1 (DE)
Inventor: THOMAS GRIFFITH R
IPC: C07K14/52
Filed: 1997-01-13
Granted: 2008-11-27
Abstract: The present invention is directed to the surprising and unexpected finding that biologically active thrombopoietin materials can be administered with substantial therapeutic effect at dosage rates commensurate with previously reported administration of such materials, but in a single or low-multiple daily administration. Thus, the predicate of the present invention relates to the reversal of thrombocytopenia by administering to a patient having or in need of such treatment a single or low-multiple daily dose of a therapeutically effective amount of a thrombopoietin. The preferable dose of the active material ranges from about 1 to about 10  mu g/kg body weight.
Patent DE-69807934-D1 (DE)
Inventor: RING JOHN
IPC: B05D1/24
Filed: 1998-12-16
Granted: 2002-10-17
Abstract: A process for forming a coating on a conductive substrate, which comprises establishing a fluidized bed of a powder coating composition, in which the mechanism for particle charging is tribostatic charging immersing the substrate wholly or partly within the said fluidized bed, applying a voltage to the substrate for at least part of the period of immersion, whereby particles of the powder coating composition adhere to the substrate, withdrawing the substrate from the fluidized bed and forming the adherent particles into a continuous coating over at least part of the substrate.The process enables the coating of substrate areas which, because of the Faraday cage effect, are inaccessible in conventional electrostatic coating processes, and also enables the formation of thinner coatings than are obtainable by conventional fluidized-bed processes.
Patent DE-69813845-D1 (DE)
Inventor: HAGIYA HIROSHI
IPC: A61K48/00
Filed: 1998-06-23
Granted: 2003-05-28
Abstract: A novel plasmid DNA containing a reporter gene DNA; a transformant prepared by using the above plasmid DNA and a known DNA encoding effector proteins; remedies for cancer or autoimmune diseases containing both the DNAs as the active ingredients; and a method for detecting a ligand of an intranuclear receptor by using the above transformant.
Patent DE-69818712-D1 (DE)
Inventor: SOTING TOR
IPC: B23K9/073
Filed: 1998-03-03
Granted: 2003-11-06
Abstract: The present invention relates to a method of controlling a welding power source and the associated wire feed arrangement intended for arc welding operations that employ a consumable electrode, to ensure crater filling at the end of the welding operation by means of fading of the arc voltage and of the wire feed rate, respectively. More particularly the invention relates to a method comprising arc voltage reduction at the onset of the end of the welding operation for a period that is considerably briefer than the total fading time, during which the arc voltage is reduced to a value below the value at which it is possible to weld during continuous welding and advancement in the joint with otherwise unchanged welding parameters, followed by a further reduction to a final value of arc voltage and fading of the wire feed rate simultaneously with the arc voltage fading to a final value of the wire feed rate.
Patent DE-69818874-D1 (DE)
Inventor: BARTON RUSSEL H
IPC: H01M8/02
Filed: 1998-07-15
Granted: 2003-11-13
Abstract: An electrochemical fuel cell stack with an improved compression assembly comprises a tension member which is electrically non-conductive and preferably non-metallic. The tension member can be made from a composite material which has similar expansion and contraction properties as the stack materials, thereby reducing undesirable fluctuations in the compressive force applied to the stack. An improved apparatus for securing the improved tension member to the rest of the compression assembly is also provided. Preferred embodiments of an improved compression assembly employ a collet and wedges to grip the tension member and compress a resilient member which imparts a tensile force to the tension member and a compressive force to the fuel cell assemblies. In other embodiments, an improved compression assembly employs a unitary resilient member and fastener in combination with a tension member. The improved apparatus is easier to assemble in high speed manufacturing processes because the compression assembly can be assembled or installed using the same machinery which is used to compress the stack in one fixturing because the compression assembly is assembled by being stacked in essentially the same direction as the other fuel cell components. An improved method of assembling a compression assembly for an electrochemical fuel cell stack is also provided.
Patent DE-69820858-D1 (DE)
Inventor: BENESI STEVE C
IPC: B01D25/127
Filed: 1998-01-28
Granted: 2004-02-05
Abstract: PCT No. PCT/US98/01717 Sec. 371 Date Jul. 1, 1999 Sec. 102(e) Date Jul. 1, 1999 PCT Filed Jan. 28, 1998 PCT Pub. No. WO98/33573 PCT Pub. Date Aug. 6, 1998A modular filter apparatus is formed from stacked filter modules. Slurry to be filtered flows into the apparatus through a flowmeter and check valve into a header. The flow of slurry then branches off through feeders to each of the filter modules. Connected to the header is a slurry supply source, a cakewash supply source and a header drain. The modules are coupled to a hydraulic jack mechanism and an upper strongback.
Patent DE-69822300-D1 (DE)
Inventor: CALDWELL SCOTT
IPC: A61P25/28
Filed: 1998-04-22
Granted: 2004-04-15
Abstract: Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia) are treated by administering an <u>endo</u> or <u>exo</u> form of a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a 1-aza-2-(3-pyridyl)bicyclo[2.2.2] octane, a 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane.
Patent DE-69823380-D1 (DE)
Inventor: BEST EDWARD
IPC: B01J2/02
Filed: 1998-10-12
Granted: 2004-05-27
Abstract: Process for the preparation of melamine from urea via a high-pressure process in which dry melamine powder is obtained by transferring the melamine melt leaving the reactor to a vessel in which the melamine melt is cooled by means of ammonia characterized in that the melamine melt is sprayed into a cooling vessel and cooled by droplets of evaporating liquid ammonia which is sprayed into the same cooling vessel at a pressure above 0.1 MPa and a temperature between 50° C. and the melting point of the melamine in the cooling vessel.
Patent DE-69826694-D1 (DE)
Inventor: TUNCEL H
IPC: B29B17/00
Filed: 1998-07-17
Granted: 2004-11-04
Abstract: This invention is related to the method of benefiting from waste polyurethane foam material which is one of the used refrigerator material as an input material in production of a composite material, and the composite material produced with this method. The pieces, attained by grounding the polyurethane foam materials are compressed under the mechanical pressure and with the effect of the heat and bounded to the polyurethane bond former. A mixture attained by breaking into pieces the thermoplastic-based cardboard boxes used in boxes of beverages is also added to the polyethylene lot to increase the mechanic durability of the product.
Patent DE-69828288-D1 (DE)
Inventor: MAUDUIT NICOLAS
IPC: G01J5/20
Filed: 1998-08-07
Granted: 2005-01-27
Abstract: Highly thermally isolated pixel-array radiation sensor elements, preferably each (i) KTN material with (ii) an optional radiation-wavelength-tuned absorption coating (iii) suspended above a common substrate by surface micromachining, are continuously illuminated with thermal radiation from a scene so as to each come to an associated thermal equilibrium temperature, and so as to each produce an associated electrical signal. Each and every sensor is occasionally, preferably periodically on the order of seconds, momentarily, typically on the order of milliseconds, subjected to a thermal pulse, preferably as is generated by discharge of an associated local capacitor into a typically polysilicon local resistor. In accordance with the material used, and the "gain" of the thermal sensor element, the heat pulse will produce a large change in the electrical signal from which charge the equilibrium temperature, even if very small and even if resulting from long-wavelength low-energy thermal radiation, is accurately deduced. A sensor element typically 80  mu m square typically has thermal conductivity in the range of range of 6x10-13 to 8x10-13 W/ DEG  K., and heat capacity in the range of 4x10-14 J/ DEG  K. to 7x10-14 J/ DEG  K.
Patent DE-69840276-D1 (DE)
Inventor: KOHL PAUL A
IPC: H01L21/312
Filed: 1998-01-21
Granted: 2009-01-08
Abstract: A method of forming an air gap (26) or gaps within solid structures and specifically semiconductor structures to reduce capacitive coupling between electrical elements such as metal lines, wherein a norbornene-type polymer is used as a sacrificial material (20) to occupy a closed interior volume in a semiconductor structure. The sacrificial material (20) is caused to decompose into one or more gaseous decomposition products which are removed, preferably by diffusion, through an overcoat layer (24). The decomposition of the sacrificial material leaves an air gap or gaps (26) at the closed interior volume previously occupied by the norbornene-type polymer. The air gaps may be disposed between electrical leads to minimize capacitive coupling therebetween. <IMAGE> <IMAGE>
Patent DE-69841815-D1 (DE)
Inventor: BACA MANUEL
IPC: C12P21/02
Filed: 1998-04-03
Granted: 2010-09-16
Abstract: Humanized and variant anti-VEGF antibodies and various uses therefore are disclosed. The anti-VEGF antibodies have strong binding affinities for VEGF; inhibit VEGF-induced proliferation of endothelial cells  in vitro,  and inhibit tumor growth  in vivo.
Patent DE-69901536-D1 (DE)
Inventor: FOGH JENS
IPC: C12N9/88
Filed: 1999-01-27
Granted: 2002-06-27
Abstract: A method for treatment or prophylaxis of disease caused by deficiency, in a subject, of an enzyme belonging to the heme biosynthetic pathway, the method comprising administering, to the subject, an effective amount of a catalyst which is said enzyme or an enzymatically equivalent part or analogue thereof. The disease is selected from the group consisting of, acute intermittent porphyria (AIP), ALA deficiency porphyria (ADP), Porphyria cutanea tarda (PCT), Hereditary coproporphyria (HCP), Harderoporphyria (HDP), Variegata porphyria (VP), Congenital erythropoietic porphyria (CEP), Erythropoietic protoporphyria (EPP), and Hepatoerythropoietic porphyria (HEP). The catalyst is an enzyme selected from the group consisting of porphobilinogen deaminase (PBGD) ALA dehydratase, Uroporphyrinogendecarboxylase, Coproporphyrinogen oxidase, Coproporphyrinogen oxidise, Protoporphyrinogen oxidase, Uroporphyrinogen III synthase, Ferrochelatase, and Uroporphyrinogen decarboxylase, or an enzymatically equivalent part or analogue thereof. In addition the invention relates to the use of PBGD and to a method of gene therapy.
Patent DE-69902499-D1 (DE)
Inventor: RAMBOZ MAURICE
IPC: B65G65/00
Filed: 1999-05-05
Granted: 2002-09-19
Abstract: The assembly consists of a pair of augers to discharge the material through a central outlet hopper (14), with drives situated between the horizontal branches (15,16) of a sideways U-shaped frame (4). The frame is hollow and has an access port (29) for maintenance via a chamber (B) beneath the assembly which is reached from outside the silo. The frame contains systems for handling and maneuvering the drives.
Patent DE-69907652-D1 (DE)
Inventor: WILHELM BERNARD
IPC: B64D47/02
Filed: 1999-02-24
Granted: 2003-06-12
Abstract: The invention concerns lighting means compatible with a light-intensifying night vision imaging system, comprising at least an electroluminescent source of polychromatic white light (15) with high radiant energy in violet/blue wavelength band of and with low residual energy in red wavelength band.
Patent DE-69909810-D1 (DE)
Inventor: PASCHKE E
IPC: C08J5/00
Filed: 1999-10-05
Granted: 2003-08-28
Abstract: Processes for producing aromatic monomers useful for forming polyesters are disclosed. Cost effective steps employed in the processes permit small amounts of process-related materials typically removed from monomer to remain in an aromatic monomer product. In many cases, the presence of the process-related materials left in the monomer product by the cost effective process steps can enhance the performance of the monomer in certain applications. Aromatic monomer products and polymers produced therefrom having these advantages also are disclosed, as well as products such as pasteurizable bottles made from these polymers.
Patent DE-69916856-D1 (DE)
Inventor: OSBORNE DAVID
IPC: A61J3/06
Filed: 1999-09-03
Granted: 2004-06-03
Abstract: Microparticles comprising or consisting of a therapeutic agent, having a relative particle density of at least 80% of the agent, and a shape factor of 1-5, are new. Independent claims are also included for: (1) a needleless syringe comprising microparticles as above; (2) production of the microparticles comprising spray-drying a solution or a suspension comprising the therapeutic agent.
Patent DE-69925267-D1 (DE)
Inventor: WU WEI
IPC: C12P13/04
Filed: 1999-03-10
Granted: 2005-06-16
Abstract: 2-Aminopropane is used as the amine donor in the stereoselective synthesis of a chiral amine from a ketone with a transaminase. In a typical embodiment, (S)-1-methoxy-2-aminopropane is prepared by bringing methoxyacetone into contact with a transaminase in the presence of 2-aminopropane as an amine donor until a substantial amount of methoxyacetone is converted to (S)-1-methoxy-2-aminopropane and 2-aminopropane is converted to acetone. In a second embodiment, L-alanine is prepared by bringing pyruvic acid into contact with a transaminase in the presence of 2-aminopropane as an amine donor.
Patent DE-69925279-D1 (DE)
Inventor: LOPEZ ANGEL
IPC: C07K16/28
Filed: 1999-08-13
Granted: 2005-06-16
Abstract: A method of isolating a monoclonal antibody capable of inhibiting any one of IL-3, GM-CSF and IL-5 binding to the common receptor beta<SUB>c</SUB>, or a monoclonal antibody capable of inhibiting the cytokines binding to a receptor analogous to beta<SUB>c</SUB>. The method includes the steps of immunizing an animal with a cytokine receptor or portion of a cytokine containing the critical binding site which portion includes the extracellular domain 4 or analogous domain in the analogous common receptor or part thereof. Antibodies producing cells from the animal are then isolated and fused with a myeloma cell line and then screened for a cell line that produces an antibody of the desired type. A monoclonal antibody, or fragments thereof capable of inhibiting the binding of the cytokines IL-3, GM-CSF and IL-5 to the beta<SUB>c </SUB>receptor, and a hybridoma cell line producing the antibody are also claimed.